Testing an Experimental Coronavirus Vaccine

March 2, 2020

Testing an Experimental Coronavirus Vaccine

An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna is ready to enter human testing, announced NIAID director Anthony Fauci. This rapid response, getting a vaccine into phase I trials within three months of the sequencing of the virus, is a new record. Yourway has extensive experience in supporting accelerated clinical trials when the need is acute.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Schedule a Meeting

Media

Articles

Why Alignment Matters in Clinical Logistics

Open chat

Hello! How can I help you?